Trinity Biotech PLC ( NASDAQ:TRIB) reported a 3% year-on-year revenue growth, driven by TrinScreen HIV revenues. The company is making significant progress in the development of its next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback